Yohimbine

The VerdictLOW CONVICTION

Your "stubborn fat" pill has better evidence for erections than for fat loss, and its most reliable effect is a racing heart.

Before you buy a "stubborn fat" fat-burner with yohimbine in it, ask one question: do you have any heart condition, high blood pressure, anxiety/panic history, or are you on an SSRI or another stimulant? If yes to any, skip it — the risk is real and the fat-loss benefit isn't proven. If no, know this: a calorie deficit is what actually burns the fat, and yohimbine hasn't been shown to add to it. Either way, you probably just saved your money.

Yohimbine comes from the bark of an African tree, and it works by cutting the "stop" wire on your fat cells. Your body keeps a brake on releasing fat, strongest in lower-body "stubborn" areas, and yohimbine snips that brake. The catch: letting fat out of storage isn't the same as burning it off your body. Without a calorie shortfall it just goes back, and the same wire it cuts also revs up your heart and nerves.

That's the general answer. Your stack is different.

Check your whole stack

Before buying a "stubborn fat" fat-burner, ask one question: do you have any heart condition, high blood pressure, anxiety or panic history, or are you on an SSRI or another stimulant?

If yes to any of those, skip it — the cardiovascular and anxiety risk is real and the fat-loss benefit isn't proven. If no, remember the deficit is what burns the fat; yohimbine hasn't been shown to add to it. Either way, you probably just saved your money.

Takes 30 seconds. No equipment needed.

The Protocol

If you use it at all. Trial-grade dosing, by goal. Start low; effects on blood pressure and anxiety scale with the dose.

Use (population)	Dose	Timing	Form	Loading
Fat loss (lean only, if at all)	10-20mg/day (0.1-0.2mg/kg), split	Fasted, pre-cardio	Yohimbine HCl, standardized	No
Erectile dysfunction (historical)	15-30mg/day (trials up to 42mg)	Daily or on-demand	Yohimbine HCl	No
Acute performance	2.5mg (only dose tested)	20 min pre-exercise	Yohimbine HCl	No

There is no established safe upper limit for yohimbine as a supplement. The "fasted" instruction is not bro-science: food raises insulin, and insulin shuts off the only fat mechanism yohimbine has.

Which form

Yohimbine HCl

standardized · quantified

The only form with real trial dosing. How much reaches your blood is governed by your CYP2D6 gene.

Yohimbe bark extract

content often mislabeled

Frequently does not state, or contain, the dose implied. Adds dosing uncertainty for no benefit.

"Alpha-yohimbine" / rauwolscine

no human data

Marketed as "stronger." No adequate human absorption or outcome data supports it.

Safety & Interactions

This is where yohimbine earns its conviction, in the wrong direction. The sympathetic "fight-or-flight" effect is the most reliably replicated thing it does in humans.

CYP2D6-inhibiting drugs (many SSRIs, bupropion, some heart-rhythm meds) — Avoid

They raise yohimbine levels from the same dose, so a "normal" dose becomes a much bigger hit.

MAO inhibitors — Avoid

Additive adrenaline load with a real risk of a dangerous blood-pressure spike.

Other stimulants / caffeine / pre-workouts — Don't stack

Additive blood-pressure and anxiety load. Most "fat burners" already pile these together.

Tricyclic antidepressants — Avoid / monitor

Additive cardiovascular and adrenergic effects.

Don't use it at all if you are

Hypertensive or have any cardiovascular disease — it pushes blood pressure the wrong way.
Prone to anxiety, panic, or PTSD — it reliably provokes anxiety, and induced panic in 6 of 11 susceptible patients in one study.
Pregnant — the stimulant load is inappropriate.
Dependent on opioids — it can precipitate withdrawal-like symptoms.

Common side effects: raised blood pressure and heart rate, anxiety and jitteriness, headache, nausea, sweating, insomnia if taken late. All scale with the dose and with your individual sensitivity. Upper limit: none established for supplement use.

Conviction: Low-to-Moderate

Erectile dysfunction: MODERATE (a real meta-analysis signal, but dated and outclassed by modern ED drugs). Fat loss for the general buyer: LOW. Acute performance: LOW / EMERGING. Safety as a reliable stimulant: HIGH — but that's a hazard, not a benefit.

What would change this

An independent, double-blind, placebo-controlled trial of at least 150 overweight (not lean-athlete) adults taking standardized yohimbine HCl 10-20mg/day fasted before exercise for 12+ weeks, with body-fat measured by DXA under a verified calorie deficit and CYP2D6 genotype reported, showing a meaningful fat-loss advantage over placebo, would move general-consumer fat loss from LOW to MODERATE.

Worth Your Money?

Weekly cost~£1-4 per week at 10-20mg/day. Cheap is not the point.

Worth it ifHonestly, rarely. For erectile dysfunction it has been replaced by safer, far more effective prescription options. For fat loss the benefit isn't established.

Lower priority ifYour next £20 is almost always better spent on the things that actually move fat loss: hitting your protein, fixing your sleep, and keeping training consistent. A stimulant doesn't fix any of those.

Skip

Go Deeper

Want to stop wasting money on supplements that don't work, and dodge the ones that can hurt you? The Verdict reviews one every week, free.

Join The Verdict — free

Claims vs Evidence — See What the Research Found

What People Claim

"Yohimbine finally gets at the stubborn fat your diet leaves behind — the lower-belly and lower-body fat. Take it fasted, first thing, before cardio, and it unlocks the fat that won't budge. Bonus: it boosts libido and gives you clean energy."

The pitch has real science under it. Stubborn fat genuinely is rich in the receptors yohimbine blocks, and the "take it fasted" instruction is mechanistically sound. The problem is the gap between what it does in a lab and what it does to a normal person's body composition, plus a safety profile the label never leads with.

What the Evidence Actually Shows

Claimed benefit	Strength	What the data shows
Erectile dysfunction	MODERATE	Meta-analysis of 7 trials, OR 3.85 over placebo (Ernst & Pittler 1998). Real, but dated and outclassed by PDE5 inhibitors.
Fat loss (general buyer)	LOW	A weight-loss systematic review declined to call it effective (Pittler & Ernst 2005).
Fat loss (lean athletes)	WEAK	One small trial: body fat 9.3%→7.1% on 20mg/day in elite soccer players (Ostojić 2006). Doesn't generalize.
Stubborn-fat mobilization	MECH	Real pharmacology: it disinhibits fat release in stubborn depots. No body-composition payoff demonstrated.
Acute anaerobic performance	EMERGING	One 18-person trial; sprint power up but the effect size was trivial (η²=0.024).
Anxiety / blood-pressure rise	HIGH	Dose-dependent BP rise to +28 mmHg systolic; panic induced in 6/11 susceptible people. The best-replicated effect.

The Full Picture — Mechanism, Debate & Nuance

How It Works

Yohimbine blocks alpha-2 adrenergic receptors. Those receptors act as a self-limiting brake in two places that matter. On nerve endings they shut off further adrenaline release; on fat cells they suppress fat breakdown. Block them and you release both brakes at once, which raises "fight-or-flight" tone, adrenaline, blood pressure, and arousal.

The fat-loss theory hangs entirely on the fat-cell half. These brake-receptors are densest in the lower-body and lower-belly "stubborn" depots, so blocking them there should let circulating adrenaline mobilize fat that otherwise resists. That part is genuinely true. The leap that fails is the next one: pulling a fatty acid out of a fat cell is not the same as losing it. With no calorie shortfall, it gets re-stored or simply burned instead of another fuel. Two facts the marketing omits: insulin overrides the whole mechanism (the real reason to take it fasted), and exercising muscle already locally quiets these receptors anyway.

The Debate

Does it actually burn fat?

Ostojić 2006 [unverified]

Body fat 9.3%→7.1% in lean soccer players on 20mg/day.

Pittler & Ernst 2005 SR

Yohimbine not established as an effective weight-loss agent.

Why they differ: a depot effect in already-lean, hard-training athletes in an energy-controlled setting is not a weight-loss drug for the average consumer.

Is the ED benefit still relevant?

Meta-analysis (PMID 9649257)

OR 3.85 favoring yohimbine over placebo for ED.

Modern practice

Yohimbine is essentially obsolete for ED.

Why they differ: the meta-analysis predates sildenafil. "Better than placebo in 1996" is not "useful in 2026" once a far better, safer standard of care arrived.

Honest Limitations

Population mismatch

The one supportive fat-loss study used lean elite athletes in a managed protocol. The buyer is usually a non-athlete wanting a shortcut, exactly the group where the body's energy compensation bites hardest.

Label accuracy

"Yohimbe bark extract" capsules often do not state, or do not contain, the dose implied. The trials used quantified yohimbine HCl. You may be taking far more or far less than you think.

The pharmacogenetic lottery

Your CYP2D6 gene and any interacting drug swing how much of a given dose reaches your bloodstream. The dose on the label is not the dose your body sees, and the gap can be the difference between "nothing" and a panic attack.

The Nuance

Who, if anyone, has a case for it: lean, healthy athletes already in a verified deficit with no cardiovascular or anxiety history and no interacting drugs, and historically men with erectile dysfunction, who are now better served by first-line prescription options. Everyone else looking for it to "melt" fat is better served by the boring truth: a sustained calorie deficit does that job, and yohimbine has not been shown to add to it.

What doesn't work

"Burns stubborn fat off your body." It can mobilize fat from stubborn depots; it has not been shown to produce net fat loss without a deficit. Mobilization is not loss.
"Spot-reduces your lower belly / hips." Spot reduction is not a real outcome, regardless of where the receptors sit.
"Alpha-yohimbine / rauwolscine is a stronger, better version." No adequate human data supports superiority.
A reliable, predictable dose. Genetic variability and label inaccuracy make consistent dosing a genuine problem.

Sources

Ernst E, Pittler MH (1998). Yohimbine for erectile dysfunction: a systematic review and meta-analysis of RCTs. J Urol. 7 RCTs; OR 3.85 (95% CI 2.22-6.67) over placebo.
Carey MP, Johnson BT (1996). Effectiveness of yohimbine in the treatment of erectile disorder: four meta-analytic integrations. Arch Sex Behav. Consistent ED benefit; reporting flaws noted.
Pittler MH, Ernst E (2005). Complementary therapies for reducing body weight: a systematic review. Int J Obes. Yohimbine not established as effective for weight loss.
Ostojić SM (2006). Yohimbine: effects on body composition and exercise performance in soccer players. Res Sports Med. N=20, 20mg/day × 21d; body fat 9.3%→7.1%. [cite-unverified]
Acute Yohimbine HCl Supplementation on Repeated Supramaximal Sprint Performance (2022, PMID 35162339). N=18, 2.5mg acute; sprint power up, η²=0.024.
Goldberg MR, Robertson D (1983). Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines (PMID 6352483). Dose-related BP rise up to +28 mmHg systolic.
Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and controls (1997, PMID 9247979). Panic induced in 6/11 patients vs 0 controls.
Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity (2020, PMID 32060866). Yohimbine PK is CYP2D6-dependent; altered by paroxetine.